Skip to main content
. 2020 Jul 23;3(7):e208215. doi: 10.1001/jamanetworkopen.2020.8215

Table 3. Outcomes for Patients With Neither Severe Cerebral Edema nor Highly Malignant EEG Treated With TTM at 33 °C or 36 °C.

Outcome No. (%)
TTM at 33 °C (n = 489) TTM at 36 °C (n = 422)
Survived hospitalization 171 (35.0) 168 (39.8)
ICU length of stay, median (IQR), d 9 (5-18) 8 (5-15)
Hospital length of stay, median (IQR), d 17 (11-26) 16 (10-24)
Modified Rankin Scale
0 7 (4.1) 2 (1.2)
1 11 (6.4) 10 (6.0)
2 21 (12.3) 23 (13.7)
3 22 (12.9) 24 (14.3)
4 67 (39.2) 67 (39.9)
5 43 (25.1) 42 (25.0)
Cerebral performance category
1 18 (10.5) 11 (6.5)
2 25 (14.6) 26 (15.5)
3 113 (66.0) 122 (72.6)
4 15 (8.8) 9 (5.4)
Died in hospital 319 (65.2) 253 (60.0)
ICU length of stay, median (IQR), d 3 (1-5) 2 (1-5)
Mode of death
Rearrest, intractable shock, or multiple organ failure 87 (27.3) 100 (39.5)
WLST, nonneurological reasons 35 (11.0) 64 (25.3)
WLST, neurological prognosis 174 (54.5) 75 (29.6)
Brain death 22 (6.9) 15 (5.9)

Abbreviations: ICU, intensive care unit; IQR, interquartile range; TTM, targeted temperature management; WLST, withdrawal of life-sustaining therapies.